Cabaletta Bio, Inc. (CABA) Financials

CABA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 173.3 million 12.4 million
2023-06-30 184.6 million 10.5 million
2023-03-31 103.4 million 11.8 million
2022-12-31 117.0 million 12.4 million

CABA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -12.7 million 3.0 million
2023-06-30 -11.9 million 2.8 million
2023-03-31 -13.0 million 2.5 million
2022-12-31 -12.4 million 1.6 million

CABA Net Income

No data available :(

CABA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 164.4 million - 4.3 million
2023-06-30 176.3 million - 4.2 million
2023-03-31 93.8 million - 4.7 million
2022-12-31 106.5 million - 5.1 million

CABA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 44.0 million
2023-06-30 39.2 million
2023-03-31 35.4 million
2022-12-31 30.2 million

CABA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 65000 13.8 million 4.9 million -
2023-06-30 57000 11.8 million 4.1 million -
2023-03-31 380000 12.4 million 4.5 million -
2022-12-31 316000 12.4 million 3.9 million -

CABA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 355000
2023-06-30 - 833000
2023-03-31 - 817000
2022-12-31 - 2.9 million

CABA

Price: $12.39

52 week price:
7.69
26.35

Earnings Per Share: -1.65 USD

P/E Ratio: -14.71

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 489500

Market Capitalization: 907.9 million

Links: